BR0207948A - Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade - Google Patents

Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade

Info

Publication number
BR0207948A
BR0207948A BR0207948-8A BR0207948A BR0207948A BR 0207948 A BR0207948 A BR 0207948A BR 0207948 A BR0207948 A BR 0207948A BR 0207948 A BR0207948 A BR 0207948A
Authority
BR
Brazil
Prior art keywords
composition
age
related physiological
deficits
increases longevity
Prior art date
Application number
BR0207948-8A
Other languages
English (en)
Inventor
Armand Malnoe
Sylvie Pridmore-Merten
Original Assignee
Produits Nestel S A Soc D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produits Nestel S A Soc D filed Critical Produits Nestel S A Soc D
Publication of BR0207948A publication Critical patent/BR0207948A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"COMPOSIçãO QUE MELHORA OS DéFICITS FISIOLóGICOS RELACIONADOS COM A IDADE E QUE AUMENTA A LONGEVIDADE". A invenção refere-se a uma composição alimentícia pretendida para prevenir ou para restaurar os déficits funcionais relacionados com a idade em mamíferos, que compreende uma combinação que é capaz de imitar os efeitos da restrição calórica sobre a expressão gênica, a dita combinação contendo pelo menos uma molécula que estimula o metabolismo energético da célula e pelo menos um antioxidante.
BR0207948-8A 2001-03-09 2002-03-07 Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade BR0207948A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200871 2001-03-09
PCT/EP2002/002862 WO2002071874A2 (en) 2001-03-09 2002-03-07 Composition improving age-related physiological deficits and increasing longevity

Publications (1)

Publication Number Publication Date
BR0207948A true BR0207948A (pt) 2004-07-27

Family

ID=8179979

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207948-8A BR0207948A (pt) 2001-03-09 2002-03-07 Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade

Country Status (17)

Country Link
US (2) US20040047896A1 (pt)
EP (1) EP1372412A2 (pt)
JP (1) JP2004519241A (pt)
KR (1) KR20030088453A (pt)
CN (1) CN1638650A (pt)
AR (1) AR032974A1 (pt)
AU (1) AU2008201296A1 (pt)
BR (1) BR0207948A (pt)
CA (1) CA2439078C (pt)
EA (1) EA006429B1 (pt)
IL (2) IL157367A0 (pt)
MX (1) MXPA03007802A (pt)
NO (1) NO20033941L (pt)
PE (1) PE20020987A1 (pt)
PL (1) PL363426A1 (pt)
WO (1) WO2002071874A2 (pt)
ZA (1) ZA200307865B (pt)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
EP1243273A1 (en) † 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
EP1350435B1 (en) * 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
CA2498199C (en) * 2002-09-09 2012-01-17 Nestec S.A. Orally administrable composition for improving hair and coat quality
FI20022175A0 (fi) * 2002-12-10 2002-12-10 Labmax Oy Elintarvikeöljyvalmiste ja sen käyttö
US20040191775A1 (en) * 2003-03-12 2004-09-30 Spindler Stephen R. Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
US7332178B2 (en) * 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
EP1687008B1 (en) * 2003-11-21 2024-04-17 Société des Produits Nestlé S.A. Food composition comprising glucosamine
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
CA2553690C (en) 2004-01-22 2016-05-24 Sung Lan Hsia Topical co-enzyme q10 formulations and methods of use
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
JP2007289001A (ja) * 2004-05-10 2007-11-08 Toyo Shinyaku:Kk ポリフェノールを含有する食品
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
AU2012211482B2 (en) * 2004-05-27 2014-08-21 Mars, Incorporated Pet food compositions and methods
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
JP2006014730A (ja) * 2004-05-31 2006-01-19 Toyo Shinyaku:Kk 食品
JPWO2005123058A1 (ja) * 2004-06-15 2008-04-10 大阪府 老化防止剤
ES2304585T3 (es) * 2004-09-21 2008-10-16 Nestec S.A. Longevidad mejorada de gatos de avanzada edad.
EP1645276A1 (en) * 2004-10-08 2006-04-12 Wageningen Centre for Food Sciences Treatment of neurodegenerative disorders
AU2005304546B2 (en) * 2004-11-09 2011-07-21 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
JP4820760B2 (ja) * 2004-12-03 2011-11-24 キッコーマン株式会社 水溶性乾燥食品
CN101084003A (zh) * 2004-12-21 2007-12-05 重症救护联络公司 治疗性营养组合物或联合药物及其使用方法
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
ES2436181T3 (es) * 2004-12-29 2013-12-27 Hill's Pet Nutrition Inc. Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CN101128109B (zh) * 2004-12-30 2013-07-03 希尔氏宠物营养品公司 提高老年动物的生活质量的方法
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
US7198834B2 (en) * 2005-03-22 2007-04-03 Hewlett-Packard Development Company, L.P. Imaging media including interference layer for generating human-readable marking on optical media
WO2006113752A1 (en) 2005-04-19 2006-10-26 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
EP1890688A2 (en) * 2005-06-14 2008-02-27 Nestec S.A. Nutritional method
WO2007009111A1 (en) * 2005-07-14 2007-01-18 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
WO2007029730A1 (ja) * 2005-09-06 2007-03-15 Meiji Dairies Corporation 老人性貧血を防止又は治療するためのアミノ酸組成物
JPWO2007034852A1 (ja) 2005-09-22 2009-03-26 株式会社カネカ 延命用組成物及び寿命を延長する方法
WO2007038466A2 (en) * 2005-09-27 2007-04-05 Cobb & Company Treatment of bipolar disorder utilizing anti-fungal compositions
WO2007041643A1 (en) * 2005-10-03 2007-04-12 University Of Tennessee Research Foundation Dietary calcium for reducing the production of reactive oxygen species
MX2008009574A (es) 2006-02-01 2008-09-04 Nestec Sa Sistema y metodos nutricionales para aumentar la longevidad.
CN101420965B (zh) * 2006-02-15 2013-08-07 雀巢产品技术援助有限公司 长双歧杆菌在制备预防和治疗炎症的药物中的用途
US7960605B2 (en) 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
EP2004201B1 (en) * 2006-03-29 2018-08-08 Nestec S.A. Dietary supplements containing probiotics
US20070286932A1 (en) * 2006-06-07 2007-12-13 The Procter & Gamble Company Natural preservatives for preservation of perishable products
PL2023945T3 (pl) * 2006-06-08 2020-04-30 Iams Europe B.V. Kompozycja poprawiająca zdrowie oczu
JP5281234B2 (ja) * 2006-06-27 2013-09-04 ポーラ化成工業株式会社 毛様体過緊張による疲れ目の改善・予防のための経口投与組成物
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
EP2036552B1 (en) * 2006-07-05 2018-08-08 Kao Corporation Senescence inhibitor
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US20090038024A1 (en) * 2007-06-19 2009-02-05 The Regents Of The University Of California Cap/sorbs1 and diabetes
DE102007030495A1 (de) * 2007-06-30 2009-01-15 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
US20100129467A9 (en) 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
CA2704098C (en) 2007-10-26 2018-01-02 Chemaphor Inc. Compositions and methods for enhancing immune response
CN101868230A (zh) * 2007-11-20 2010-10-20 明治乳业株式会社 干红细胞的分化促进剂和/或增殖促进剂以及用于预防或治疗老年性贫血的蛋氨酸应用和含有蛋氨酸的组合物
BRPI0908414A2 (pt) * 2008-02-07 2015-08-04 Nestec Sa Composições e métodos para influenciar recuperação a partir de atividade física esforçada
WO2009126764A1 (en) 2008-04-11 2009-10-15 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
EP2123171A1 (de) * 2008-05-20 2009-11-25 Otto Thannesberger Futtermischung
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US20110189303A1 (en) * 2008-07-18 2011-08-04 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
BRPI0917866A2 (pt) * 2008-08-15 2016-11-29 Nestec Sa métodos para intensificar o metabolismo energético
US20100112181A1 (en) * 2008-10-30 2010-05-06 Matthew Joel Taylor Recovery of Antioxidants from Decaffeination Process
US20100112136A1 (en) * 2008-10-30 2010-05-06 Susan Ruth Ward Pet food composition comprising an antioxidant component
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2424512B1 (en) * 2009-04-30 2020-06-03 Avivagen Inc. Methods and compositions for improving the health of animals
SG175993A1 (en) 2009-05-11 2011-12-29 Berg Biosystems Llc Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
AU2011203800A1 (en) * 2010-01-06 2012-07-19 Nestec S.A. Dietary regimens useful for mimicking caloric restriction
EP2444083A1 (en) * 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake
AU2011328073A1 (en) * 2010-11-11 2013-05-02 Nestec S.A. Frozen confections containing probiotic micro-organisms
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
EP2658546B1 (en) * 2010-12-31 2018-12-05 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
WO2012138765A1 (en) 2011-04-04 2012-10-11 Berg Pharma Llc Methods of treating central nervous system tumors
EP2532355A1 (en) * 2011-06-06 2012-12-12 Nestec S.A. Chicory for prevention and treatment of neurodegeneration
JP2014518071A (ja) * 2011-06-15 2014-07-28 エヌエスイー プロダクツ インコーポレイテッド カロリー制限およびカロリー制限模倣物の同定用マーカー
WO2013012760A1 (en) 2011-07-15 2013-01-24 Numeta Sciences, Inc. Compositions and methods for modulating metabolic pathways
CA2848038C (en) * 2011-09-09 2021-04-20 Kemin Industries, Inc. Antioxidant formulations
FR2982460B1 (fr) * 2011-11-14 2016-08-05 Virbac Sa Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
WO2014027864A1 (ko) * 2012-08-16 2014-02-20 경희대학교 산학협력단 노화 및 치매의 예방 및/또는 치료 활성을 갖는 유산균
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
JP2016512021A (ja) 2013-03-08 2016-04-25 アクシオム フーズ インコーポレイテッド 米タンパク質補助食品
JP2016513966A (ja) * 2013-03-15 2016-05-19 ニューサート サイエンシーズ， インコーポレイテッド サーチュイン活性化剤によるペットの処置
SG11201507046UA (en) 2013-03-15 2015-10-29 Nusirt Sciences Inc Leucine and nicotinic acid reduces lipid levels
SG10201903112WA (en) 2013-04-08 2019-05-30 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
EA034143B1 (ru) 2013-09-04 2020-01-09 Берг Ллк Способы лечения рака непрерывной инфузией кофермента q10
CN103461674B (zh) * 2013-09-23 2014-12-31 大连圣弘医药有限公司 一种能够有效活化宠物关节的宠物功能食品配方及其制备方法
US20150164833A1 (en) * 2013-12-17 2015-06-18 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of ursolic acid and uses thereof
MX2016011063A (es) 2014-02-27 2016-11-30 Nusirt Sciences Inc Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
AU2015202755B2 (en) * 2014-05-21 2017-05-04 Medlab Ip Pty Ltd Probiotic combinations and uses thereof
WO2016133909A1 (en) 2015-02-16 2016-08-25 Mars, Incorporated Interlocking kibble
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof
JP6966784B2 (ja) 2016-03-26 2021-11-17 学校法人 川崎学園 老化を反映するミトコンドリアバイオマーカー
USD806351S1 (en) 2016-09-06 2018-01-02 Mars, Incorporated Food product
USD805728S1 (en) 2016-09-06 2017-12-26 Mars, Incorporated Food product
IT201600111275A1 (it) * 2016-11-04 2018-05-04 Centro Dermatologico S R L Metodo di trattamento cosmetico
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
US11284640B2 (en) * 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
IT201800000890A1 (it) * 2018-01-15 2019-07-15 Sirt500 Sagl Composizione nutraceutica per l’attivazione delle sirtuine con effetto anti-aging/reverse-aging
CN109045059A (zh) * 2018-08-01 2018-12-21 泓博元生命科技（深圳）有限公司 一种抗衰老、提高男性精力的组合物、制剂及其制备方法与应用
US20220008489A1 (en) * 2018-09-26 2022-01-13 Meiji Co., Ltd. Agent for improving mitochondrial function
US11767314B2 (en) 2018-11-02 2023-09-26 Conopco, Inc. Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same
CA3119100C (en) * 2018-11-09 2024-06-04 Valter D. Longo Nutrition bar for intermittent fasting-mimicking
JP2022539872A (ja) * 2019-07-12 2022-09-13 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 局所組成物及びミトコンドリア断片化に対するそれの使用方法
CN112080507B (zh) * 2020-09-04 2022-04-08 扬州大学 一种调控银杏类黄酮合成的关键基因GbMYB4及其表达的蛋白、载体和应用
CN112079911B (zh) * 2020-09-04 2022-04-08 扬州大学 一种促进银杏类黄酮合成的关键基因GbMYB6及其表达的蛋白、载体和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
US4330557A (en) * 1979-05-21 1982-05-18 Claudio Cavazza Acyl-carnitine and use thereof in parenteral administration of triglycerides
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US4883672A (en) * 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
WO1998043617A2 (en) * 1997-03-27 1998-10-08 Sole Michael J Nutritional composition for improvements in cell energetics
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
FR2761887B1 (fr) * 1997-04-11 1999-06-18 Roland Asmar Medicament visant a la prevention multifactorielle des maladies cardiovasculaires
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US5926849A (en) * 1998-03-31 1999-07-27 Boyle; Kevin J. Baseball cap with a channeled, laminated inside head band
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
CA2389623A1 (en) * 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
WO2001051088A1 (en) * 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
US20010043983A1 (en) * 2000-01-25 2001-11-22 Hamilton Nathan D. Nutritional supplements for aged pets
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
CA2498199C (en) * 2002-09-09 2012-01-17 Nestec S.A. Orally administrable composition for improving hair and coat quality
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물

Also Published As

Publication number Publication date
IL157367A (en) 2006-07-05
AU2008201296A1 (en) 2008-04-17
PE20020987A1 (es) 2002-12-17
ZA200307865B (en) 2005-01-10
US20040047896A1 (en) 2004-03-11
EA006429B1 (ru) 2005-12-29
CA2439078A1 (en) 2002-09-19
US20050100617A1 (en) 2005-05-12
NO20033941D0 (no) 2003-09-05
MXPA03007802A (es) 2003-12-08
CA2439078C (en) 2009-08-25
AR032974A1 (es) 2003-12-03
KR20030088453A (ko) 2003-11-19
NO20033941L (no) 2003-09-05
EP1372412A2 (en) 2004-01-02
WO2002071874A3 (en) 2003-01-09
JP2004519241A (ja) 2004-07-02
EA200300994A1 (ru) 2004-02-26
CN1638650A (zh) 2005-07-13
WO2002071874A2 (en) 2002-09-19
PL363426A1 (en) 2004-11-15
IL157367A0 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
BR0207948A (pt) Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
BRPI0515316A (pt) compostos de imidazoquinolina
BRPI0410124A (pt) composições para cuidados pessoais com múltiplas fases
BRPI0409591A (pt) composições com múltiplas fases lìquidas visualmente distintas
ES2196860T3 (es) Nuevas indolinonas sustituidas con efecto inhibidor sobre diferentes cinasas y diferentes complejos ciclina/cdk.
BR0008447A (pt) Métodos de tratamento de distúrbios mitocondriais
BR9908020A (pt) Fórmula para polimento ótico
ATE457726T1 (de) Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen
BR0004240A (pt) Ingrediente alimentar funcional de soja inovador
BRPI0508098A (pt) compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
BR0211814A (pt) Formulação contendo (liso-)fosfatidilserina para a prevenção e tratamento de estados de tensão em animais de sangue quente
BR0009564A (pt) Utilização de inibidores da cyp2d6 em terapias de combinação
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
BR0317822A (pt) Composição fluoroquìmica
BRPI9807124B8 (pt) composições compreendendo uma combinação de uma base esfingóide livre e uma ceramida e seus usos.
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR9814698A (pt) Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
WO2002068680A3 (en) Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR0211245A (pt) Alimento contendo proteìna compreendendo uma enzima de ligação cruzada e um hidrocolóide
BR0107262C1 (pt) Composição a base de monoterpenos, com efeito, quimiopreventivo e quimioterápico em neoplasias malignas de seres humanos e animais, utilização dos monoterpenos na inbição do crescimento de células tumorais e no controle de metástases de tumores primários e método especìfico de utilização da composição, com efeito, quimiopreventivo e quimioterápico em seres humanos e animais
BR0210696A (pt) Emplastros do tipo folha
BR0213299A (pt) Utilização de cistationina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 9A. E 10A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.

B15K Others concerning applications: alteration of classification

Ipc: A23K 50/40 (2016.01), A23L 33/15 (2016.01), A23L 3